Log In
Print
BCIQ
Print
Print this Print this
 

CEP-37250, KHK2804

  Manage Alerts
Collapse Summary General Information
Company Allara Therapeutics Inc.
DescriptionHumanized antibody dependent cellular cytotoxicity (ADCC)-enhanced antibody targeting a novel carbohydrate antigen
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today